Food-grade organisms as vaccine biofactories and oral delivery vehicles

S Rosales-Mendoza, C Angulo, B Meza - Trends in Biotechnology, 2016 - cell.com
The use of food-grade organisms as recombinant vaccine expression hosts and delivery
vehicles has been explored during the past 25 years, opening new avenues for vaccinology …

Lactococci and lactobacilli as mucosal delivery vectors for therapeutic proteins and DNA vaccines

LG Bermúdez-Humarán, P Kharrat, JM Chatel… - Microbial cell …, 2011 - Springer
Abstract Food-grade Lactic Acid Bacteria (LAB) have been safely consumed for centuries by
humans in fermented foods. Thus, they are good candidates to develop novel oral vectors …

Lactic acid bacteria—promising vaccine vectors: possibilities, limitations, doubts

K Szatraj, AK Szczepankowska… - Journal of Applied …, 2017 - academic.oup.com
Gram‐positive, nonpathogenic lactic acid bacteria (LAB) are considered to be promising
candidates for the development of novel, safe production and delivery systems of …

Edible genetically modified microorganisms and plants for improved health

A Mercenier, U Wiedermann, H Breiteneder - Current Opinion in …, 2001 - Elsevier
The development of new strategies for the delivery of vaccine antigens or immune
modulators to the mucosal tissue includes innovative approaches such as the use of …

Targeting ideal oral vaccine vectors based on probiotics: a systematical view

B Jiang, Z Li, B Ou, Q Duan, G Zhu - Applied Microbiology and …, 2019 - Springer
Probiotics have great potential to be engineered into oral vaccine delivery systems, which
can facilitate elicitation of mucosal immunity without latent risks of pathogenicity. Combined …

[HTML][HTML] Lactococcus lactis: A new strategy for vaccination

M Azizpour, SD Hosseini, P Jafari… - Avicenna journal of …, 2017 - ncbi.nlm.nih.gov
Needle free vaccines have a several advantages and very attractive way for vaccination. In a
body, mucosal surfaces provide a universal entry portal for all the known and emerging …

Lactic acid bacteria as live vaccines

A Mercenier, H Müller-Alouf, C Grangette - Current issues in molecular …, 2000 - mdpi.com
Mucosal routes for vaccine delivery offer several advantages over systemic inoculation from
both immunological and practical points of view. The development of efficient mucosal …

Engineering lactococci and lactobacilli for human health

LG Bermúdez-Humarán, C Aubry, JP Motta… - Current opinion in …, 2013 - Elsevier
Highlights•Recombinant lactococci and lactobacilli have been successfully used in the last
years as safe mucosal delivery vectors for molecules of health interest.•The delivery of …

Challenges in mucosal vaccines for the control of infectious diseases

T Azegami, Y Yuki, H Kiyono - International immunology, 2014 - academic.oup.com
The mucosal surface is the largest route through which pathogens enter the human body. To
control the outbreak of mucosal infectious diseases, we must use our knowledge of the …

Lactic acid bacteria: reviewing the potential of a promising delivery live vector for biomedical purposes

O Cano-Garrido, J Seras-Franzoso… - Microbial cell …, 2015 - Springer
Lactic acid bacteria (LAB) have a long history of safe exploitation by humans, being used for
centuries in food production and preservation and as probiotic agents to promote human …